<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Tseng HY</submitter><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Hepatorenal syndrome (HRS) is a disastrous renal complication of advanced liver disease with a poor prognosis. Restoring normal liver function through liver transplantation (LT) is a standardized treatment with favorable short-term survival. However, the long-term renal outcomes in patients with HRS receiving living donor LT (LDLT) are controversial. This study aimed to investigate the prognostic impact of LDLT in patients with HRS.&lt;h4>Methods&lt;/h4>We reviewed adult patients who underwent LDLT between July 2008 and September 2017. Recipients were classified into 1) HRS type 1 (HRS1, &lt;i>N&lt;/i> = 11), 2) HRS type 2 (HRS2, &lt;i>N&lt;/i> = 19), 3) non-HRS recipients with pre-existing chronic kidney disease (CKD, &lt;i>N&lt;/i> = 43), and 4) matched normal renal function (&lt;i>N&lt;/i</pubmed_abstract><journal>Frontiers in surgery</journal><pagination>1116728</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10106629</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-term renal outcomes comparison between patients with chronic kidney disease and hepatorenal syndrome after living donor liver transplantation.</pubmed_title><pmcid>PMC10106629</pmcid><pubmed_authors>Chen CL</pubmed_authors><pubmed_authors>Yong CC</pubmed_authors><pubmed_authors>Tseng HY</pubmed_authors><pubmed_authors>Lin YH</pubmed_authors><pubmed_authors>Lin CC</pubmed_authors><pubmed_authors>Lin LM</pubmed_authors><pubmed_authors>Chan YC</pubmed_authors><pubmed_authors>Wang CC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term renal outcomes comparison between patients with chronic kidney disease and hepatorenal syndrome after living donor liver transplantation.</name><description>&lt;h4>Background and aims&lt;/h4>Hepatorenal syndrome (HRS) is a disastrous renal complication of advanced liver disease with a poor prognosis. Restoring normal liver function through liver transplantation (LT) is a standardized treatment with favorable short-term survival. However, the long-term renal outcomes in patients with HRS receiving living donor LT (LDLT) are controversial. This study aimed to investigate the prognostic impact of LDLT in patients with HRS.&lt;h4>Methods&lt;/h4>We reviewed adult patients who underwent LDLT between July 2008 and September 2017. Recipients were classified into 1) HRS type 1 (HRS1, &lt;i>N&lt;/i> = 11), 2) HRS type 2 (HRS2, &lt;i>N&lt;/i> = 19), 3) non-HRS recipients with pre-existing chronic kidney disease (CKD, &lt;i>N&lt;/i> = 43), and 4) matched normal renal function (&lt;i>N&lt;/i</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-18T14:52:47.271Z</modification><creation>2025-04-07T01:12:08.214Z</creation></dates><accession>S-EPMC10106629</accession><cross_references><pubmed>37077866</pubmed><doi>10.3389/fsurg.2023.1116728</doi></cross_references></HashMap>